SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X is trending as a Bitcoin-native meme coin launched via the Runes protocol, generating buzz for its fair distribution and strong community. Discussions highlight its potential to drive utility and transaction volume on the Bitcoin network, with many touting it as a leader in the current cycle. Community members are actively promoting its unique position compared to other meme coins and speculating about potential exchange listings.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

ProShares Short Dow30 ($DOG) is trending as community members highlight its potential as the 'meme face of Bitcoin'. Many view $DOG as more than just a memecoin, emphasizing its fair launch, community ownership, and listing on major crypto exchanges. The 'cult-like army' backing the coin and its potential to mirror $SHIB's success on ETH are also driving interest.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending amid speculation around a potential licensing deal with AstraZeneca, with community members discussing the impact of recent trial data and a possible buyout. Some investors are analyzing trial endpoints and revenue potential, while others are comparing SMMT to competitors like IOVA. The community is closely watching for further developments and official announcements.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

$BROKE.X is trending amid community excitement around staking application launch and ongoing buy contests. The community buzzes about the coin's strong performance relative to $SOL.X and anticipates further burns as watcher numbers climb. Enthusiastic community members highlight the project's doxxed developers and active engagement.

Chewy, Inc. operates as an online retailer of pet food and other pet-related products and services. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. It has a portfolio of pet healthcare offerings that includes Chewy Pharmacy, Connect with a Vet, and CarePlus, an exclusive suite of pet-first insurance and wellness plans. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Plantation, FL.

Chewy Inc - Ordinary Shares - Class A

Chewy Inc

Chewy is trending as investors digest the latest earnings report and guidance, with community members actively discussing the company's market position and future growth prospects. While some express disappointment, others point to positive aspects of the report and reiterate long-term bullish sentiment, viewing any price drops as buying opportunities. Technical analysis and analyst ratings are also contributing to the ongoing conversation around $CHWY.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending due to a significant land sale agreement, potentially boosting its NAV. The community is discussing the stock's low float and potential for a substantial price increase, with some highlighting potential squeeze dynamics. Bullish sentiment appears to be building, driven by the company's real estate assets and upcoming shareholder meeting.

This platform is engineered to unlock the full potential of Real-World Assets (RWAs) by bringing them onto the XRP Ledger with unparalleled efficiency. Our purpose is to democratize access to high-value assets by providing a streamlined, end-to-end solution for tokenization. Functionally, we offer tools for asset verification, compliant legal wrapping, and the minting of RWA tokens. The project's core utility is twofold: for asset owners, it unlocks immediate liquidity and access to global capital markets; for investors, it offers fractional, transparent, and liquid access to investment classes like private equity and infrastructure bonds. We leverage the XRPL's native speed and built-in DEX to ensure low-cost transactions and instant settlement, setting a new standard for RWA interoperability and finance.

VOLT

VOLT ($XVM.X) is trending as discussions revolve around its potential integration with established platforms like XRP and its role in tokenizing real-world assets (RWA). Community members are actively speculating on entry points, potential profits, and where to purchase the token, while also debating its legitimacy and long-term prospects.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

NTLA is trending amid discussions about its gene therapy pipeline and recent safety data from a Phase 3 trial; the community is weighing the long-term potential against short-term risks. Some traders are focusing on analyst ratings and potential for a sector rotation, while others discuss potential acquisition scenarios and ARK Invest's position in the stock. Overall, the conversation revolves around the balance between gene editing's promise and the volatility of clinical trials.

EQT Corp. is a natural gas production company, which engages in the provision of supply, transmission, and distribution of natural gas. The company was founded in 1888 and is headquartered in Pittsburgh, PA.

EQT Corp

EQT is trending following news of a major LNG deal with NextDecade, potentially boosting long-term earnings and adding momentum towards a final investment decision on Rio Grande Train 5. Community members are discussing the strategic implications of the deal and updated price targets from Bank of America, with some expressing optimism and buying dips. Overall sentiment suggests the company is well-positioned for growth within the natural gas sector.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

ABBV is trending as community members discuss its potential moves in the psychedelic drug space following a recent acquisition, with some suggesting further buyouts of companies like ATAI and CYBN. Also under discussion is AbbVie's oncology pipeline, particularly the potential acquisition of $SLS, driven by promising GPS immunotherapy data. Bullish sentiment is further fueled by updated ratings and price targets from analysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Citi Trends, Inc. (NASDAQ: CTRN)

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Citi Trends, Inc. (NASDAQ: CTRN) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of...

Citi Trends Announces 2024 Holiday Sales Results for Quarter-to-Date Through January 4, 2025

Citi Trends, Inc. (NASDAQ: CTRN), a leading specialty value retailer of apparel, accessories and home trends for way less spend primarily for African American and multicultural families in the United...

Citi Trends to Present at 2025 ICR Conference

SHAREHOLDER ALERT: Purcell and Lefkowitz LLP Announces Shareholder Investigation of Citi Trends, Inc. (NASDAQ: CTRN)

Shares of Citi Trends Inc. ($CTRN ) were up 4% ahead of its third-quarter results, with retail sentiment remaining cautious to bullish with many of its competitors.&nbsp; Wall Street consensus estimates expect the company to post earnings per share of -$0.66 on revenues of $179.1 million. The company has missed estimates thrice out of the last four quarters. Its stock price, meanwhile, has rallied over the past month, reaching a month-high on Monday.&nbsp; In the second quarter, it posted a wider net loss of $18.4 million ($16.2 million adjusted), compared to a net loss of $5.0 million ($4.9 million adjusted) in the same quarter in 2023. Its total sales increased by 1.7%, but comparable store sales declined by 1.7%. That quarter, it also incurred $13.4 million in one-time expenses, including $9.4 million it spent clearing aged inventory. Last month, Citi Trends’ board named Kenneth (Ken) Seipel as CEO from Interim CEO and also appointed Peter Sachse, then executive chairman, as chairman. Announcing its preliminary Q3 2024 results also in November, it said last month its Q3 sales results are expected to be above the company’s previous outlook. Gross margin for Q3 2024 is expected to be 39.8%, an increase of 160 basis points compared to Q3 2023. Q3 2024 adjusted Earnings before Interest, Tax, Depreciation, and Amortization (EBITDA) is expected to be a loss of $3.3 million, which includes strategic costs for in-depth customer and market research and costs to improve operational processes.&nbsp; Citi Trends is a retailer of urban fashion apparel, accessories, and home trends. Its brands include 'Citi Steps' and 'Red Ape,’ and it operates 592 stores across 33 states. <a href="https://stocktwits.com/symbol/CTRN">Citi Trends stock</a> is down 26% year-to-date. &nbsp;For updates and corrections email newsroom[at]stocktwits[dot]com. &nbsp;

Citi Trends operates 592 stores located in 33 states.| Image source: Pexels

Citi Trends Stock Rallies Ahead of Q3 Results

Last month, Citi Trends announced its board named Kenneth (Ken) Seipel as CEO from Interim CEO and also appointed Peter Sachse as chairman.

Equity

Last month, Citi Trends announced its board named Kenneth (Ken) Seipel as CEO from Interim CEO and also appointed Peter Sachse as chairman.


Citi Trends Announces CEO Appointment and Q3 Comparable Store Sales Above Guidance

Citi Trends Inc. (NASDAQ: CTRN) today announced the Board of Directors has appointed Kenneth (Ken) Seipel as Chief Executive Officer, effective November 18, 2024. Mr. Seipel has been serving as the...

Citi Trends Sets Date for Third Quarter 2024 Earnings Release and Conference Call

Citi Trends, Inc. (NASDAQ: CTRN) today announced plans to release its earnings for the third quarter 2024 before the market opens on Tuesday, December 3, 2024. Citi Trends will host a conference call...

Citi Trends Announces Second Quarter Fiscal 2024 Results

Citi Trends Sets Date for Second Quarter 2024 Earnings Release and Conference Call

Citi Trends, Inc. (NASDAQ: CTRN) today announced plans to release its earnings for the second quarter 2024 before the market opens on Tuesday, August 27, 2024. Citi Trends will host a conference call...

Citi Trends Announces 4th Annual Black History Makers Grant Winners

Citi Trends, Inc. engages in the retail of urban fashion apparel, accessories, and home trends. It offers products under its Citi Steps and Red Ape brands. The company was founded in 1946 and is headquartered in Savannah, GA.

CTRN
Citi Trends Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CTRN News

CTRN Citi Trends Inc